Literature DB >> 7074614

Genetic instability coupled to clonal selection as a mechanism for tumor progression in the Dunning R-3327 rat prostatic adenocarcinoma system.

J T Isaacs, N Wake, D S Coffey, A A Sandberg.   

Abstract

The androgen-sensitive Dunning R-3327-H prostatic adenocarcinoma has been maintained by continuous serial passage in intact male rats for many years. While it has been possible to maintain the original characteristics of the well-differentiated H tumor over 16 years, there have evolved spontaneously, however, more aberrant sublines from this tumor at several subpassages in intact male rats. Serial passage of these individual sublines has established five additional R-3327 tumors each with distinct phenotypes and each more aberrant than the parent H tumor. In addition, it has been possible by passage of the H tumor in castrated male rats to obtain a well-differentiated slow-growing adrogen-insensitive tumor termed the Hl-S tumor. The continuous serial passage of this Hl-S tumor has likewise resulted in the emergence of three new types of Dunning tumors. The results from the biochemical and chromosomal studies presented demonstrate that there is a consistent association in each of these tumor progressions between the expression of genetic instability, which results in the addition of phenotypically new clones of cells to the tumor population, and the subsequent selection of these newly developed clone. These results suggest that the process of genetic instability coupled to clonal selection is one mechanism for the change in tumor phenotype characteristically associated with tumor progression within this system of prostatic tumors.

Entities:  

Mesh:

Year:  1982        PMID: 7074614

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  31 in total

Review 1.  Targeting anti-apoptotic genes upregulated by androgen withdrawal using antisense oligonucleotides to enhance androgen- and chemo-sensitivity in prostate cancer.

Authors:  Martin E Gleave; Toby Zellweger; Kim Chi; Hideaki Miyake; Satoshi Kiyama; Laura July; Simon Leung
Journal:  Invest New Drugs       Date:  2002-05       Impact factor: 3.850

2.  Low-calcium serum-free defined medium selects for growth of normal prostatic epithelial stem cells.

Authors:  Ivan V Litvinov; Donald J Vander Griend; Yi Xu; Lizamma Antony; Susan L Dalrymple; John T Isaacs
Journal:  Cancer Res       Date:  2006-09-01       Impact factor: 12.701

3.  The role of stress proteins in prostate cancer.

Authors:  Alan So; Boris Hadaschik; Richard Sowery; Martin Gleave
Journal:  Curr Genomics       Date:  2007-06       Impact factor: 2.236

Review 4.  Prostate cancer stem cells.

Authors:  Shi-Ming Tu; Sue-Hwa Lin
Journal:  Clin Genitourin Cancer       Date:  2012-03-14       Impact factor: 2.872

5.  The epithelial origin of a stromal cell population in adenocarcinoma of the rat prostate.

Authors:  W C Beckman; J L Camps; R M Weissman; S L Kaufman; S J Sanofsky; R L Reddick; G P Siegal
Journal:  Am J Pathol       Date:  1987-09       Impact factor: 4.307

6.  The effect of a combination of zindoxifene and cisplatin on Dunning R3327-G prostatic carcinomas of the rat.

Authors:  E von Angerer; H Birnböck; M Kager; A Maucher
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

Review 7.  Mechanisms involved in the progression of androgen-independent prostate cancers: it is not only the cancer cell's fault.

Authors:  J T Arnold; J T Isaacs
Journal:  Endocr Relat Cancer       Date:  2002-03       Impact factor: 5.678

Review 8.  Somatic cell fusion as a source of genetic rearrangement leading to metastatic variants.

Authors:  L Larizza; V Schirrmacher
Journal:  Cancer Metastasis Rev       Date:  1984       Impact factor: 9.264

9.  The selective nature of metastasis.

Authors:  J E Talmadge
Journal:  Cancer Metastasis Rev       Date:  1983       Impact factor: 9.264

Review 10.  Development of androgen-independent tumor cells and their implication for the treatment of prostatic cancer.

Authors:  J T Isaacs; N Kyprianou
Journal:  Urol Res       Date:  1987
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.